Health

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs in the body, including the kidneys. A recent analysis of medical records suggested that individuals with SLE who were taking metformin had lower rates of lupus nephritis, chronic kidney disease (CKD), and major adverse cardiovascular events (MACE) compared to those not
0 Comments
Patients with rheumatoid arthritis (RA) can greatly benefit from regular high-sensitivity cardiac troponin T (hs-cTnT) testing, according to researchers. In a study conducted at Brigham and Women’s Hospital in Boston, RA patients who tested positive for hs-cTnT were found to have a significantly increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, even
0 Comments
A recent study sheds light on the missed opportunities in treating drug overdose survivors covered by the Medicare program. The study highlights the complexities involved in managing chronic pain and addiction. According to the findings published in JAMA Internal Medicine, overdose survivors on Medicare in 2020 were disproportionately prescribed opioid painkillers rather than receiving proper
0 Comments
In a recent announcement by the FDA, two new immunotherapy-chemotherapy options have been approved for patients with primary advanced or recurrent endometrial cancer. This approval opens up new possibilities for treatment for individuals with both mismatch repair (MMR)-deficient and MMR-proficient disease. The first immunotherapy option approved is the PD-1-directed immune checkpoint inhibitor pembrolizumab, in combination
0 Comments
Dr. Dean Ornish from the University of California San Francisco has discovered that an intensive lifestyle intervention may help slow down early Alzheimer’s disease. During his research, he found that the only side effects of this intervention were positive ones. This groundbreaking discovery could potentially change the way we approach treating Alzheimer’s disease in the
0 Comments
The landscape of healthcare delivery has been drastically changed by the recent COVID-19 pandemic, prompting a shift towards remote monitoring and telemedicine. During a late-breaking abstract session at the European Alliance of Associations for Rheumatology (EULAR) annual meeting, Dr. Inger Jorid Berg presented findings from a randomized trial that evaluated different approaches to follow-up care
0 Comments
Air pollution is a growing concern not only for the environment but also for human health, particularly for pregnant women. Recent studies have uncovered a troubling connection between maternal exposure to particulate matter (PM) and adverse outcomes during pregnancy, specifically related to blood pressure issues. This overlooked risk to maternal health highlights the urgent need
0 Comments
Advancements in the field of oncology have paved the way for innovative treatment options for patients with non-small cell lung cancer (NSCLC). In a recent phase II study conducted in collaboration with UT Southwestern, patients with EGFR-mutant NSCLC were treated with osimertinib alone or in combination with stereotactic ablative radiation therapy (SABR). The study aimed
0 Comments
The story of Barbara Quarrell, a cancer patient who was denied care at Memorial Medical Center in Las Cruces, New Mexico, highlights a troubling trend in the healthcare system. The hospital, now owned by private equity-backed Lifepoint Health, refused to accept Barbara’s insurance, leaving her with limited options for treatment. This case is not isolated,
0 Comments